The primary mechanisms of action include: Enhancing insulin secretion from pancreatic beta cells in a glucose-dependent manner, which helps lower blood glucose levels without causing hypoglycaemia when used alone Suppressing glucagon release from pancreatic alpha cells, reducing hepatic glucose production Slowing gastric emptying , which prolongs the feeling of fullness after meals Acting on appetite centres in the brain , particularly the hypothalamus, to reduce hunger and food intake GLP-1 receptor agonists are typically administered via subcutaneous injection, with dosing frequencies ranging from once daily to once weekly depending on the specific medication, though oral semaglutide (Rybelsus) is also available
Sodium promotes fluid retention
Early Treatment Phase: In the first few weeks, appetite drops and calorie intake often changes quickly
Whether its weight loss, metabolic health, or longevity, every Vyora product is evidence-informed, prescribed by licensed clinicians, and dispensed through trusted U.S
